NASDAQ:POAI Predictive Oncology (POAI) Stock Price, News & Analysis → get a piece of the profit from this land (From True Market Insiders) (Ad) Free POAI Stock Alerts $1.68 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$1.65▼$1.7650-Day Range$1.15▼$2.9052-Week Range$1.12▼$7.12Volume29,290 shsAverage Volume488,840 shsMarket Capitalization$6.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Predictive Oncology alerts: Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. About Predictive Oncology Stock (NASDAQ:POAI)Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.Read More POAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart POAI Stock News HeadlinesMay 16 at 10:39 AM | uk.finance.yahoo.comQ1 2024 Predictive Oncology Inc Earnings CallMay 16 at 10:39 AM | finance.yahoo.comPredictive Oncology Inc (POAI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 15 at 7:25 PM | finanznachrichten.dePredictive Oncology Inc.: Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 15 at 11:20 AM | investorplace.comPOAI Stock Earnings: Predictive Oncology Reported Results for Q1 2024May 15 at 7:00 AM | globenewswire.comPredictive Oncology Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 13, 2024 | americanbankingnews.comPredictive Oncology (POAI) to Release Quarterly Earnings on WednesdayMay 11, 2024 | americanbankingnews.comPredictive Oncology (NASDAQ:POAI) Stock Price Passes Below 200 Day Moving Average of $2.76May 10, 2024 | globenewswire.comPredictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024May 8, 2024 | investorplace.comThe 3 Most Undervalued AI Penny Stocks to Buy in May 2024May 8, 2024 | investorplace.comAI-Fueled Penny Stocks: 3 High-Risk, High-Reward OpportunitiesMay 1, 2024 | msn.comWall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top ForecastsApril 30, 2024 | finance.yahoo.comOnyxia Introduces AI to Cybersecurity Management Platform to Power Predictive Security Program ManagementApril 30, 2024 | msn.comPredictive Oncology stock rallies 30% post-market on vaccine collaborationApril 30, 2024 | finance.yahoo.comPredictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu VaccineApril 25, 2024 | msn.comMiMedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare moversApril 25, 2024 | finance.yahoo.comFujifilm and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of BiopharmaceuticalsApril 24, 2024 | globenewswire.comPredictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 24, 2024 | investorplace.com3 AI Penny Stocks With Massive Growth Potential: April EditionApril 23, 2024 | investing.comPredictive Oncology Inc (POAI)April 22, 2024 | finance.yahoo.comDigital Twins and Predictive Maintenance market is projected to grow at a CAGR of 46.3% by 2034: VisiongainApril 22, 2024 | finance.yahoo.comHealthcare Predictive Analytics Research Report 2024: Global Market to Reach $34 Billion by 2030, Driven by Advanced Data Tools and Value-Based CareApril 19, 2024 | msn.comPredictive Oncology, BIMI Holdings, IMAC Holdings among healthcare moversApril 11, 2024 | finance.yahoo.comPredictive Maintenance Market Worth $47.8 billion by 2029, Growing At a CAGR of 35.1% Report by MarketsandMarkets™April 2, 2024 | finance.yahoo.comPredictive Oncology Inc. (NASDAQ:POAI) Q4 2023 Earnings Call TranscriptApril 2, 2024 | finance.yahoo.comQ4 2023 Predictive Oncology Inc Earnings CallSee More Headlines Receive POAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today5/18/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:POAI CUSIPN/A CIK1446159 Webwww.precisiontherapeutics.com Phone(651) 389-4800FaxN/AEmployees34Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,980,000.00 Net Margins-754.13% Pretax Margin-754.13% Return on Equity-151.51% Return on Assets-91.35% Debt Debt-to-Equity RatioN/A Current Ratio1.45 Quick Ratio2.43 Sales & Book Value Annual Sales$1.78 million Price / Sales3.87 Cash FlowN/A Price / Cash FlowN/A Book Value$0.99 per share Price / Book1.70Miscellaneous Outstanding Shares4,100,000Free Float3,961,000Market Cap$6.89 million OptionableNot Optionable Beta1.39 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Raymond F. Vennare (Age 71)CEO & Chairman Comp: $525kMr. Joshua Blacher M.B.A. (Age 51)Interim Chief Financial Officer Ms. Theresa FergusonSenior Director of MarketingDr. Lawrence J. DeLucas D.ScO.D, Ph.D., Senior Vice President of BiologicsDr. Arlette H. Uihlein FCAPM.D., Senior VP of Translational Medicine & Drug Discovery and Medical DirectorKey CompetitorsHeart Test LaboratoriesNASDAQ:HSCSNanoVibronixNASDAQ:NAOVHepion PharmaceuticalsNASDAQ:HEPACadrenal TherapeuticsNASDAQ:CVKDTelesis BioNASDAQ:TBIOView All CompetitorsInsidersCharles Lee Sr Nuzum SrSold 10,000 sharesTotal: $30,400.00 ($3.04/share)View All Insider Transactions POAI Stock Analysis - Frequently Asked Questions How have POAI shares performed in 2024? Predictive Oncology's stock was trading at $3.29 at the beginning of 2024. Since then, POAI stock has decreased by 48.9% and is now trading at $1.68. View the best growth stocks for 2024 here. When is Predictive Oncology's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our POAI earnings forecast. How were Predictive Oncology's earnings last quarter? Predictive Oncology Inc. (NASDAQ:POAI) released its quarterly earnings results on Tuesday, May, 14th. The medical instruments supplier reported ($1.04) EPS for the quarter. The medical instruments supplier had revenue of $0.42 million for the quarter. Predictive Oncology had a negative net margin of 754.13% and a negative trailing twelve-month return on equity of 151.51%. When did Predictive Oncology's stock split? Shares of Predictive Oncology reverse split on the morning of Monday, April 24th 2023. The 1-20 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Predictive Oncology own? Based on aggregate information from My MarketBeat watchlists, some companies that other Predictive Oncology investors own include NVIDIA (NVDA), OPKO Health (OPK), Enphase Energy (ENPH), Inovio Pharmaceuticals (INO), Overstock.com (OSTK), Riot Platforms (RIOT), AcelRx Pharmaceuticals (ACRX), Boeing (BA), QUALCOMM (QCOM) and Sorrento Therapeutics (SRNE). How do I buy shares of Predictive Oncology? Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:POAI) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.